China NMPA Product Recall - Ventilator

The National Medical Products Administration (NMPA) published a voluntary recall notice on June 19, 2017, concerning ventilators manufactured by Philips (China) Investment Co., Ltd. The company initiated a Class I recall due to a critical issue involving data transmission failures within the affected products. This malfunction could potentially lead to serious operational problems with the ventilators, posing a significant risk to patient safety. The recall applies to specific models, specifications, and batches, identified under note 20163545139, with full details provided in the "Medical Device Recall Event Report Form." Philips (China) Investment Co., Ltd. proactively undertook this action to address the potential health risks associated with the faulty devices. A Class I recall is the most serious type, indicating a reasonable probability that using the product will cause serious adverse health consequences or death. This regulatory oversight by the NMPA ensures that medical devices adhere to established safety and performance standards, requiring manufacturers to take corrective measures when such issues arise to protect patient health. The company is responsible for retrieving and correcting the faulty devices from distribution and use.